Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT03930498 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03930498
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2023-11-22
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.